Screener
Edgewise Therapeutics, Inc. EWTX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Edgewise Therapeutics, Inc.’s reported figures.
The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 8:09 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056713
FAQ
- What is Edgewise Therapeutics, Inc.'s free cash flow?
- Edgewise Therapeutics, Inc. (EWTX) reported free cash flow of -$42.8M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s free cash flow changed year-over-year?
- Edgewise Therapeutics, Inc.'s free cash flow decreased by 12.9% year-over-year, from -$37.91M to -$42.8M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s free cash flow has grown at a 43.3% compound annual growth rate (CAGR), from -$34.18M to -$144.07M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Edgewise Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude